HK1209639A1 - Gpbp-1 inhibition and its therapeutic use gpbp-1 - Google Patents

Gpbp-1 inhibition and its therapeutic use gpbp-1

Info

Publication number
HK1209639A1
HK1209639A1 HK15110458.7A HK15110458A HK1209639A1 HK 1209639 A1 HK1209639 A1 HK 1209639A1 HK 15110458 A HK15110458 A HK 15110458A HK 1209639 A1 HK1209639 A1 HK 1209639A1
Authority
HK
Hong Kong
Prior art keywords
gpbp
inhibition
therapeutic use
therapeutic
use gpbp
Prior art date
Application number
HK15110458.7A
Other languages
English (en)
Chinese (zh)
Inventor
Juan Saus
Francisco Revert-Ros
Fernando Revert
Carmen Aguado-Velasco
Ernesto Lpez-Pascual
Alejandra Maria Prez-Sastre
Ral Blasco
Hctor Prez-Montoyo
Original Assignee
Fibrostatin S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrostatin S L filed Critical Fibrostatin S L
Publication of HK1209639A1 publication Critical patent/HK1209639A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15110458.7A 2012-07-02 2015-10-23 Gpbp-1 inhibition and its therapeutic use gpbp-1 HK1209639A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261667057P 2012-07-02 2012-07-02
PCT/EP2013/063892 WO2014006020A1 (fr) 2012-07-02 2013-07-02 Inhibition de gpbp-1 et son utilisation thérapeutique

Publications (1)

Publication Number Publication Date
HK1209639A1 true HK1209639A1 (en) 2016-04-08

Family

ID=48745948

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110458.7A HK1209639A1 (en) 2012-07-02 2015-10-23 Gpbp-1 inhibition and its therapeutic use gpbp-1

Country Status (6)

Country Link
US (2) US9066938B2 (fr)
EP (1) EP2866835A1 (fr)
JP (1) JP2015524385A (fr)
CN (1) CN104684584A (fr)
HK (1) HK1209639A1 (fr)
WO (1) WO2014006020A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3024457A4 (fr) 2013-07-26 2017-06-28 Update Pharma Inc. Compositions permettant d'améliorer l'avantage thérapeutique du bisantrène
US11045488B2 (en) 2014-12-26 2021-06-29 Nitto Denko Corporation RNA interference agents for GST-π gene modulation
US10264976B2 (en) * 2014-12-26 2019-04-23 The University Of Akron Biocompatible flavonoid compounds for organelle and cell imaging
US20160184274A1 (en) 2014-12-31 2016-06-30 Fibrostatin, S.L. Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition
WO2017134146A1 (fr) * 2016-02-02 2017-08-10 Fibrostatin, S.L. Inhibiteurs de gpbp, utilisations et synthèse évolutive associées
WO2023210713A1 (fr) * 2022-04-27 2023-11-02 国立大学法人京都大学 Promoteur de régénération de cellules épicardiques et procédé pour favoriser la régénération de cellules épicardiques

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
MXPA01008605A (es) 1999-02-24 2003-06-24 Juan Saus Proteina de enlace del antigeno goodpasture.
US6881547B1 (en) 2001-01-31 2005-04-19 Juan Saus Methods and reagents for treating autoimmune disorders
US7147855B2 (en) 2001-12-07 2006-12-12 Juan Saus GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
WO2004070025A2 (fr) 2003-02-05 2004-08-19 Juan Saus Nouvelles isoformes de la proteine liant l'antigene de goodpasture et troubles induits par une proteine incorrectement repliee
CN102300583A (zh) 2008-07-22 2011-12-28 菲布他丁有限合伙公司 Goodpasture抗原结合蛋白及其检测
JP5883794B2 (ja) 2009-11-05 2016-03-15 フィブロスタチン ソシエダ リミターダＦｉｂｒｏｓｔａｔｉｎ，Ｓｏｃｉｅｄａｄ Ｌｉｍｉｔａｄａ 擬似ｑ２ペプチドを用いるｇｐｂｐ抑制
MX2013006040A (es) * 2010-12-07 2013-08-26 Amira Pharmaceuticals Inc Antagonistas del receptor de acido lisofosfatidico y su uso en el tratamiento de fibrosis.
EP2678360A1 (fr) 2011-02-21 2014-01-01 Fibrostatin, S.L. Méthodes pour traiter et diagnostiquer une maladie

Also Published As

Publication number Publication date
US20150320730A1 (en) 2015-11-12
CN104684584A (zh) 2015-06-03
US20140005134A1 (en) 2014-01-02
EP2866835A1 (fr) 2015-05-06
WO2014006020A1 (fr) 2014-01-09
JP2015524385A (ja) 2015-08-24
US9066938B2 (en) 2015-06-30

Similar Documents

Publication Publication Date Title
IL274988A (en) Carbamoylpyridone-polycyclic compounds and their pharmaceutical use
HK1203493A1 (en) Substituted azabicycles and use thereof
GB201320729D0 (en) Therapeutic compounds and their use
EP2828258A4 (fr) Nouveaux dérivés de pyridopyrimidine et leur utilisation
EP2867209A4 (fr) Composés et leurs utilisations thérapeutiques
EP2884984A4 (fr) Compositions et procédés thérapeutiques
HK1217092A1 (zh) 治療性化合物及其用途
EP2958895A4 (fr) Composés thérapeutiques et leurs utilisations
HK1209639A1 (en) Gpbp-1 inhibition and its therapeutic use gpbp-1
HK1203198A1 (en) Substituted phenylimidazopyrazoles and use thereof
GB201311361D0 (en) Compounds and their therapeutic use
GB201308736D0 (en) Compounds and their therapeutic use
EP2939668A4 (fr) Inhibiteur pdk4 et son utilisation
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
EP2817004A4 (fr) Dérivés de bouvardine et leurs utilisations thérapeutiques
HK1207154A1 (en) C1q-adiponectin complex and use thereof c1q-
GB201317804D0 (en) Therapeutic compounds and their use
GB201316173D0 (en) Compounds and their therapeutic use
GB201307677D0 (en) Compounds and their therapeutic use